Baht 0.5 million in Q1/2019. The interest expenses in Q1/2020 was Baht 1.8 million, or 38.03% decreased from Baht 3.0 million of Q1/2019. This was due to the decrease in short term loan requirement
Business unit was decrease by THB 291 million or 12% mainly due to the soften of methyl ester price following in CPO price falling and the soften of by-product revenue from glycerin price declining, though
decrease in expenses of beauty business. 2. Financial Performance Summary – by business Revenues by business THB’000 Consolidated Q2/2020 Q2/2019 ∆% Distributor of medical devices and equipment 430,615
at 16.20% and 11.75% in the six-month period ended June 30, 2018 and the six-month period ended June 30, 2019, respectively. The period-on-period decrease in net profit to revenue ratio was because of
increase was partially offset by a decrease in interest expenses from reducing loan amounts as well as allowance reversal from debt repayment from the securities business receivable and Innotech Asset
decrease in prepaid customers resulted from subscribers moving into postpaid. Blended ARPU increased 3.6% YoY with improved pricing; and remained flat QoQ. The subscribers for FBB business grew 38% YoY, and
was mainly from the decrease in long-term loans from financial institutions due within one year 12.3 million baht. While employee benefit obligations increased 2.1 million baht. (3) Shareholders’ Equity
Baht, decline in investment money in affiliate company as amount of 20.45 Million Baht and decrease in deferred income tax of 20.41 Million Baht Source of Investment Liabilities As at June 30, 2018 the
decreased by 64% compared to the same period at the previous year. The main reason from decrease in service revenue due to Wutiisak Clinicintergroup Co., Ltd. “Wuttisak” changed business to franchise model. 2